| Alternative Name: | CA9, Carbonic anhydrase IX, CA-IX, G250, Membrane antigen MN, P54/58N, pMW1 |
| |
| MW: | ~41.2 kDa |
| |
| Source: | Produced in HEK 293 cells. Human carbonic anhydrase 9 (aa 38-414) is fused at the C-terminus to a 6xHis-tag. |
| |
| EC: | 4.2.1.1 |
| |
| UniProt ID: | Q16790 |
| |
| Formulation: | Lyophilized from 0.22µm filtered solution in 20mM MES, pH 6.5, containing 100mM NaCl. Normally mannitol or trehalose is added as protectant before lyophilization. |
| |
| Purity: | ≥95% (SDS-PAGE) |
| |
| Endotoxin Content: | <1 EU/µg (LAL method) |
| |
| Reconstitution: | Reconstitute in sterile PBS, pH 7.4, to a concentration of 50 μg/ml. |
| |
| Shipping: | Blue Ice |
| |
| Short Term Storage: | -20°C |
| |
| Long Term Storage: | -20°C |
| |
| Handling: | Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -20°C. |
| |
| Scientific Background: | Carbonic anhydrase 9 catalyzes the reversible hydration of carbon dioxide. It also participates in pH regulation. Carbonic anhydrase 9 may be involved in the control of cell proliferation and transformation. It also appears to be a novel specific biomarker for a cervical neoplasia. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
